OTTAWA, ONTARIO–(Marketwired – March 20, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in […]
OTTAWA, ONTARIO–(Marketwired – March 19, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation“) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced the [...]
MONTREAL, QUEBEC–(Marketwired – March 19, 2018) – Knight Therapeutics Inc. (TSX:GUD) (“Knight”) announced today a license agreement with Ardelyx, Inc. […]